Tolvaptan

This classification denotes a vasopressin antagonist with the molecular formula C26H25ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21G72T1950, chemically known as 7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1h-1-benzazepine but generally known as tolvaptan, which bears US NIH Compound Identifier 216237. European Medicines Agency schedules Tolvaptan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22755. The term TOLVAPTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). World Health Organization schedules tolvaptan in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tolvaptan under HS 29339930 and SITC 51577. As of Q4 2014, TOLVAPTAN remains the US FDA Preferred Term for this commodity. Tolvaptan bears US NLM identifiers UMLS ID C1176308 and NCI Concept Code C77082. SMILES: CLC1CC2C(O)CCCN(C2CC1)C(=O)C1C(CC(NC(=O)C2C(CCCC2)C)CC1)C.